Sympathomimetic Overdose With Lisdexamfetamine in a Pediatric Patient Resulting in Stress Cardiomyopathy-A Case Report.
BACKGROUND: Sympathomimetic overdoses, as seen in amphetamine ingestions, are known to have cardiac effects ranging from tachycardia and hypertension to coronary vasospasm and myocardial infarction.…
英文原文(摘要)· 点击展开
BACKGROUND: Sympathomimetic overdoses, as seen in amphetamine ingestions, are known to have cardiac effects ranging from tachycardia and hypertension to coronary vasospasm and myocardial infarction. Stress cardiomyopathy is rare in pediatric patients and has not been reported in association with the extended-release preparation of lisdexamfetamine, indicated for the treatment of attention-deficit hyperactivity disorder.
CASE SUMMARY: A 17-year-old girl presented with an intentional ingestion of lisdexamfetamine and signs and symptoms of a sympathomimetic toxidrome. She was found to have severe cardiac dysfunction, which worsened within 24 hours of ingestion and required intubation and management of acute heart failure.
CONCLUSIONS: Stress cardiomyopathy due to extended-release stimulant ingestion is a possible outcome of intentional ingestion. Providers should be vigilant and monitor for signs of cardiac dysfunction.
参考来源
- Guertin H, Pinnell R, Chen R, et al. Sympathomimetic Overdose With Lisdexamfetamine in a Pediatric Patient Resulting in Stress Cardiomyopathy-A Case Report. Crit Care Explor. 2026. PMID: 42012868. doi:10.1097/CCE.0000000000001401
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。